Claims
- 1. A method for inhibiting pro-inflammatory cytokine production under conditions where extracellular spermine levels are elevated, comprising administering an effective amount of a human fetuin polypeptide.
- 2. The method of claim 1 wherein the human fetuin polypeptide has a primary sequence according to SEQ ID NO. 1 or SEQ ID NO. 2, or a shortened fragment thereof having at least 250 amino acid residues.
CROSS REFERENCE TO RELATED APPLICATION
The present patent application is a divisional of U.S. patent application Ser. No. 08/932,871 filed Sep. 18, 1997 now U.S. Pat. No. 6,011,005.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
6011005 |
Tracey et al. |
Jan 2000 |
|
Non-Patent Literature Citations (1)
Entry |
Nelen et al., Lancet, vol. 350, Sep. 20, 1997, pp 861-862. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
932871 |
Sep 1997 |
|